title: Increased expression of MUC1 and sialyl Lewis antigens in different areas of clear renal cell carcinoma.
abstract: BACKGROUND
  Changes in expression patterns of the sialyl Lewis antigens and MUC1 mucin can be considered as markers for the diagnosis of various cancers. However, there are no reports which have been devoted to analysis of differences in the sialyl Lewis antigens and MUC1 expression patterns as potential discrimination markers among different areas of clear cell renal cell carcinoma (ccRCC). The aim of this study was to determine the level of MUC1 and specific Lewis antigens on glycoproteins in three different areas: tumor (cancer tissue), intermediate zone (adjacent to tumor tissue) and normal renal cortex/medulla (uninvolved by tumor).
  
  
  METHODS
  Study was performed on renal tissues taken from 30 patients with clear cell renal cell carcinoma. Relative amounts of sugar structures bound with proteins were determined by ELISA-like test with biotinylated lectins or monoclonal antibodies: anti-MUC1 and anti-sialyl Lewis(a/x). The study presented here provides novel information about relationship between MUC1 and sialyl Lewis antigens in the tumor, intermediate zone and noninvolved areas of normal renal tissue distant of tumor.
  
  
  RESULTS
  We have found statistically significant increase of MUC1 and sialic acid linked by α-2,3 bond with galactose in cancer tissue and in intermediate zone comparing to normal renal tissue distant of tumor. Moreover, we observed statistically significant increase of sialic acid linked by α-2,6 bond with Gal/GalNAc and sialyl Lewis(a/x) antigens in cancer tissues only, comparing to normal ones.
  
  
  CONCLUSIONS
  MUC1 and sialylated antigens can be involved in renal tumor development and can be considered as potential markers distinguishing normal renal tissue from intermediate zone and from cancer renal cells during ccRCC development.
authors.affiliation: Department of Pharmaceutical Biochemistry, Medical University of Bialystok, Mickiewicza 2A, 15-230, Białystok, Poland, gocha@umb.edu.pl.
authors.forename: Małgorzata
authors.initials: M
authors.lastname: Borzym-Kluczyk
authors.forename: Iwona
authors.initials: I
authors.lastname: Radziejewska
authors.forename: Marzanna
authors.initials: M
authors.lastname: Cechowska-Pasko
mesh_terms: D000368:Aged; D014408:Biomarkers, Tumor / Q000378:metabolism; D002292:Carcinoma, Renal Cell / Q000378:metabolism*; D005260:Female; D006801:Humans; D007668:Kidney / Q000378:metabolism; D007680:Kidney Neoplasms / Q000378:metabolism*; D016256:Lewis X Antigen / Q000378:metabolism*; D008297:Male; D008875:Middle Aged; D018396:Mucin-1 / Q000378:metabolism*; D000080506:Sialyl Lewis X Antigen
chemical_list: D014408:Biomarkers, Tumor; D016256:Lewis X Antigen; D018396:Mucin-1; D000080506:Sialyl Lewis X Antigen
references.citation: J Biol Chem. 1996 Dec 27;271(52):33325-34
references.pmid: 8969192
references.citation: Eur J Biochem. 1995 Oct 15;233(2):607-17
references.pmid: 7588808
references.citation: Mol Cell Proteomics. 2012 Jun;11(6):M111.011403
references.pmid: 22318369
references.citation: Virchows Arch. 2000 Feb;436(2):119-26
references.pmid: 10755601
references.citation: Biochem Biophys Res Commun. 1993 Sep 15;195(2):1096-103
references.pmid: 8373388
references.citation: Acta Neuropathol. 1996;91(3):284-92
references.pmid: 8834541
references.citation: Clin Exp Metastasis. 2002;19(4):339-45
references.pmid: 12090474
references.citation: Anal Biochem. 1985 Oct;150(1):76-85
references.pmid: 3843705
references.citation: Oncotarget. 2014 Feb 15;5(3):754-63
references.pmid: 24504508
references.citation: Glycoconj J. 2000 Jul-Sep;17(7-9):485-99
references.pmid: 11421344
references.citation: Nat Rev Cancer. 2009 Dec;9(12):874-85
references.pmid: 19935676
references.citation: Int J Cancer. 1989 Sep 15;44(3):434-9
references.pmid: 2476402
references.citation: Trends Cell Biol. 2006 Sep;16(9):467-76
references.pmid: 16904320
references.citation: Glycoconj J. 1997 Aug;14(5):569-76
references.pmid: 9298689
references.citation: Int J Biol Markers. 2000 Oct-Dec;15(4):343-56
references.pmid: 11192832
references.citation: Ann Hum Genet. 1987 Oct;51(4):289-94
references.pmid: 3447512
references.citation: Cancer Res. 1989 Jan 1;49(1):212-8
references.pmid: 2461798
references.citation: Oncogene. 2010 May 20;29(20):2893-904
references.pmid: 20348949
references.citation: Oncogene. 2013 Feb 28;32(9):1073-81
references.pmid: 22580612
references.citation: Cancer Res. 2009 Jul 15;69(14):5707-15
references.pmid: 19549898
references.citation: Am J Clin Pathol. 2004 Jul;122(1):61-9
references.pmid: 15272531
references.citation: J Proteome Res. 2007 May;6(5):1864-74
references.pmid: 17428079
references.citation: Am J Clin Pathol. 2002 Jul;118(1):47-51
references.pmid: 12109855
references.citation: Proc Natl Acad Sci U S A. 2002 Aug 6;99(16):10231-3
references.pmid: 12149519
references.citation: Int J Cancer. 2012 Jul 1;131(1):117-28
references.pmid: 21823122
references.citation: Clin Breast Cancer. 2013 Apr;13(2):109-18
references.pmid: 23122537